牙周再生/重建手术治疗骨内缺损的中长期临床获益:系统评价与网状Meta分析
基于21项RCT的网状Meta分析显示,OFD疗效最差,再生/重建治疗在多数比较中显著降低残余探诊深度(PD)并增加临床附着水平(CAL)获得,联合方案似乎最有效。再生/重建治疗后失牙率(0.4%)低于OFD(2.8%),但证据稀疏。
要点
- 牙周再生/重建手术在3-20年随访中较OFD显著降低残余PD并增加CAL获得。
- 联合方案在降低残余PD和增加CAL获得方面似乎优于单一疗法。
- 再生/重建治疗后失牙率0.4%,低于OFD的2.8%,但证据稀疏。
核心结论
- 牙周再生/重建治疗骨内缺损在中长期(3-20年)总体较OFD获得更浅的残余PD和更大的CAL获得,并伴随高牙存活率。
- 联合方案在降低残余PD和增加CAL获得方面似乎比单一疗法更有效,但因证据有限无法建立明确 hierarchy。
研究设计与样本
- 系统评价与网状Meta分析,纳入报告牙周再生/重建手术≥3年临床和/或影像学结局的随机对照临床试验(RCT)。
- 基于21项RCT进行贝叶斯随机效应网状Meta分析。
主要发现
- 网状Meta分析显示OFD明确为疗效最差的治疗。
- 再生/重建治疗在8项比较中的4项显示残余PD显著更浅(平均差异范围:-2.37至-0.60 mm),在8项比较中的6项显示CAL获得更大(平均差异范围:1.26至2.66 mm)。
- 再生/重建治疗后失牙率为0.4%,OFD为2.8%,但证据稀疏。
- 影像学数据稀疏,不足以进行相关比较。
临床怎么用
- 对于牙周炎伴骨内缺损患者,可考虑牙周再生/重建手术以改善中长期残余PD和CAL获得,并可能有利于牙存留。
- 联合方案可能较单一疗法提供更优的残余PD和CAL获益,但需结合个体情况与证据局限性决策。
局限性
- 影像学数据稀疏,无法进行相关比较。
- 失牙率比较的证据稀疏。
- 因证据有限,无法建立明确的治疗 hierarchy。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systematic reviews have established the short-term improvements of periodontal regenerative/reconstructive procedures compared to conventional surgical treatment in intrabony defects. However, a hierarchy of periodontal regenerative/reconstructive procedures regarding the medium- to long-term results of treatment does not exist. AIM: To systematically assess the literature to answer the focused question "In periodontitis patients with intrabony defects, what are the medium- and long-term benefits of periodontal regenerative/reconstructive procedures compared with open flap debridement (OFD), in terms of clinical and/or radiographic outcome parameters and tooth retention?". MATERIAL & METHODS: Randomized controlled clinical trials (RCTs), reporting on clinical and/or radiographic outcome parameters of periodontal regenerative/reconstructive procedures ≥3 years post-operatively, were systematically assessed. Clinical [residual probing pocket depth (PD) and clinical attachment level (CAL) gain, tooth loss] and radiographic [residual defect depth (RDD), bone gain (RBL)] outcome parameters were assessed. Descriptive statistics were calculated, and Bayesian random-effects network meta-analyses (NMA) were performed where possible. RESULTS: Thirty RCTs, presenting data 3 to 20 years after treatment with grafting, GTR, EMD, as monotherapies, combinations thereof, and/or adjunctive use of blood-derived growth factor constructs or with OFD only, were included. NMA based on 21 RCTs showed that OFD was clearly the least efficacious treatment; regenerative/reconstructive treatments resulted in significantly shallower residual PD in 4 out 8 comparisons [range of mean differences (MD): -2.37 to -0.60 mm] and larger CAL gain in 6 out 8 comparisons (range of MD: 1.26 to 2.66 mm), and combination approaches appeared as the most efficacious. Tooth loss after regenerative/reconstructive treatment was less frequent (0.4%) compared to OFD (2.8%), but the evidence was sparse. There were only sparse radiographic data not allowing any relevant comparisons. CONCLUSION: Periodontal regenerative/reconstructive therapy in intrabony defects results, in general, in shallower residual PD and larger CAL gain compared with OFD, translating in high rates of tooth survival, on a medium (3-5 years) to long-term basis (5-20 years). Combination approaches appear, in general, more efficacious compared to monotherapy in terms of shallower residual PD and larger CAL gain. A clear hierarchy could, however, not be established due to limited evidence.
引用
- Stavropoulos A, Bertl K, Spineli LM, et al. Medium- and long-term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta-analysis of randomized controlled clinical studies. J Clin Periodontol. 2021. PMID: 33289191. doi:10.1111/jcpe.13409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。